Searching for the molecular mechanism/s that could lead to higher cell death induction by 4μ8C, we assessed the release of cytokines IL-6, IL-10 and VEGF, known to sustain PEL cell survival following treatment with 4μ8C or GSK2606414 or Ceapin. This evidence concerns the gene VEGFA and primary effusion lymphoma.